End-stage Renal Disease
📧 Sign up to get email alerts when something new happens for End-stage Renal Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2025-05-29Clinical Trial Update: A Double-Blind, Randomized, Placebo-Controlled Safety Study Evaluating the Effects of Residual Renal Function (RFF) in Patients With End-Stage Renal Disease and Type 2 Diabetes Mellitus on Peritoneal Dialysis [Phase 2]
A Phase 2 double-blind, randomized, placebo-controlled safety trial evaluating the effects of residual renal function in patients with end-s…
-
CLINICAL_TRIALS withdrawal · 2025-05-09Clinical Trial Update: Improving Access to Renal Transplantation for Underserved Black Communities [NA]
A clinical trial aimed at improving access to renal transplantation for underserved Black communities was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-03-25Clinical Trial Update: Applications of MRI in Kidney Disease
A University of Minnesota-sponsored trial investigating MRI applications in kidney disease has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-03-13Clinical Trial Update: Open-label, Randomized Trial to Determine the Effect of Icodextrin Versus Dextrose (Dianeal 2.5%) in HOMA IR [Phase 4]
Phase 4 open-label randomized trial comparing icodextrin to dextrose (Dianeal 2.5%) in end-stage renal disease patients on continuous ambula…
-
CLINICAL_TRIALS withdrawal · 2025-03-03Clinical Trial Update: Effect of Extraneal (Icodextrin)on Triglyceride Levels in PD Patients [Phase 4]
Phase 4 trial evaluating Extraneal (icodextrin) and triglyceride levels in peritoneal dialysis patients was withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2025-01-29Clinical Trial Update: Special Access for the Use of Voclosporin for Kidney Transplantation
Special Access use of voclosporin for kidney transplantation has been discontinued and is no longer available.
-
CLINICAL_TRIALS withdrawal · 2024-10-01Clinical Trial Update: Ultrafiltration Efficacy of a PD Solution Containing Icodextrin-Xylitol-Carnitine [Phase 2]
A Phase 2 trial of a peritoneal dialysis solution containing icodextrin, xylitol, and carnitine has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-09-03Clinical Trial Update: Pilot Study- Treat to Target Vitamin D in End Stage Renal Disease [NA]
A pilot trial evaluating treating to target vitamin D in end-stage renal disease has been withdrawn; no results are reported.
-
CLINICAL_TRIALS withdrawal · 2024-06-21Clinical Trial Update: Safety and Tolerability of Inebilizumab, VIB4920, or the Combination in Highly Sensitized Candidates Awaiting Kidney Transplantation From a Deceased Donor [Phase 2]
Phase 2 safety/tolerability study assessing Inebilizumab, VIB4920, or their combination in highly sensitized patients awaiting deceased-dono…
-
CLINICAL_TRIALS withdrawal · 2024-06-06Clinical Trial Update: High Pressure Balloon vs Cutting Balloon [NA]
A clinical trial comparing high pressure balloon versus cutting balloon in end-stage renal disease patients on dialysis has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2022-03-08Clinical Trial Update: Single Patient Protocol for Donor HCV-positive to Recipient HCV-negative Kidney Transplant in a Patient at Risk for Loss of Dialysis Access [Phase 4]
Clinical trial for a single-patient protocol involving donor HCV-positive to recipient HCV-negative kidney transplant was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2021-11-08Clinical Trial Update: The Danish Pre-HCQ COVID Dialysis Study [Phase 4]
A Phase 4 clinical trial investigating HCQ for COVID-19 in patients on dialysis has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2021-10-21Clinical Trial Update: Dapagliflozin Effect on Cardiovascular Outcomes in Haemodialysis for End Stage Renal Disease [Phase 2, Phase 3]
A clinical trial evaluating dapagliflozin for cardiovascular outcomes in patients on haemodialysis with end-stage renal disease has been wit…
-
CLINICAL_TRIALS withdrawal · 2020-12-23Clinical Trial Update: Vitamin D and Carboxy PTH Fragments in Coronary Calcification [Phase 4]
Phase 4 trial assessing vitamin D and carboxy PTH fragments for coronary calcification has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2020-10-22Clinical Trial Update: Spironolactone Safety in Dialysis Patients [Phase 4]
A Phase 4 trial evaluating spironolactone safety in dialysis patients has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2019-02-01Clinical Trial Update: Safety and Efficacy of Plant-based Diets in Hemodialysis Patients [NA]
An interventional trial evaluating plant-based diets in patients with end-stage renal disease on hemodialysis has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2019-01-17Clinical Trial Update: Aspirin in the Prevention of Cardiovascular Events in Hemodialysis Patients [Phase 4]
A Phase 4 trial studying aspirin for prevention of cardiovascular events in patients with end-stage renal disease undergoing hemodialysis ha…
-
CLINICAL_TRIALS withdrawal · 2018-03-20Clinical Trial Update: Pharmacokinetic Assessment of Ceftazidime in Intermittent Hemodialysis Patients [Phase 4]
Phase 4 pharmacokinetic study of ceftazidime in intermittent hemodialysis patients has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-08-07Clinical Trial Update: Effects of Zortress® + Tacrolimus vs. Standard Immunosuppression on Progression of Coronary Artery Calcifications and Bone Disease in de Novo Renal Transplant Recipients [NA]
Clinical trial evaluating everolimus (Zortress) plus tacrolimus versus standard immunosuppression in de novo renal transplant recipients, fo…
-
CLINICAL_TRIALS withdrawal · 2017-06-26Clinical Trial Update: Taste And Smell TEsting in End Stage Renal Disease
The clinical trial NCT03043144 evaluating taste and smell testing in end-stage renal disease was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-05-04Clinical Trial Update: L-Arginine and Spironolactone Trial in Dialysis-Dependent ESRD [Phase 4]
A Phase 4 trial evaluating L-Arginine and Spironolactone for dialysis-dependent end-stage renal disease has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-01-12Clinical Trial Update: Assessment of a Follow-up With Tele-consulting for Patients With Renal Failure Under Peritoneal Dialysis
The clinical trial evaluating tele-consultations for patients with chronic kidney disease on peritoneal dialysis has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-01-09Clinical Trial Update: Cardiovascular Risk Following Conversion to Full Dose Myfortic® and Neoral® Two-hour Post Level Monitoring [Phase 4]
A Phase 4 trial investigating cardiovascular risk after converting kidney transplant recipients to full-dose Myfortic and Neoral with two-ho…
-
CLINICAL_TRIALS withdrawal · 2016-08-11Clinical Trial Update: A Study to Evaluate the Pharmacokinetics Of Sativex® in Subjects With Severe Renal Impairment or End Stage Renal Disease, Compared to Matched Subjects With Normal Renal Function. [Phase 1]
A Phase 1 pharmacokinetics study evaluating Sativex in subjects with severe renal impairment or end-stage renal disease has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-03-01Clinical Trial Update: Phosphorus and Calcium Removal During Long Hemodialysis Treatment Sessions [Phase 2]
Phase 2 clinical trial evaluating phosphorus and calcium removal during long hemodialysis sessions has been withdrawn by the sponsor (Indian…